Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

Senolytics

Drugs and compounds meant to clear out old, damaged cells that have stopped dividing.

How people get it: Mostly inside clinical trials. Some, such as quercetin and fisetin, are sold as supplements.

Part of Age reversal: clearing old cells

The basics

What it is

Navitoclax is a pill-form drug that blocks Bcl-2 proteins and promotes apoptosis, which is cell death.

Source: PubMed abstract: Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia. ↗

How it's thought to work

Senescent cells in melanoma release a mix of signals called SASP that changes how immune cells are recruited and work.

Source: PubMed abstract: Cellular Senescence and Immunosenescence in Melanoma: Insights From the Tumor Microenvironment. ↗

What the research has found so far

  • A review of animal studies found quercetin improved cartilage scores in osteoarthritis, a joint disease linked to aging.
  • The review authors said human trials are still needed to check if quercetin works for osteoarthritis.
  • A review of studies said clinical use of senescence-targeting approaches in melanoma needs more study to confirm safety and benefit.

Sources: PubMed abstract: pubmed.ncbi.nlm.nih.gov ↗ · PubMed abstract: Cellular Senescence and Immunosenescence in Melanoma: Insights From the Tumor Microenvironment. ↗

Clear results in animals. Early human trials are small.

On Senolytics and aging, PubMed lists 20 trials in people, 19 studies that watched people over time, 371 animal and lab studies. See the counts and searches

2
Research stage 2 of 4 · Small studies in people

Stage 2 because there are 20 published trials and 41 registered trials in people, but no large ones yet.

A stage shows how far research has got, not whether it will work for you. How stages work

Side effects and risks

In cancer patients, navitoclax caused a drop in platelets, which are blood cells that help clotting.

Source: PubMed abstract: Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia. ↗

Amounts used in studies

What studies or labels describe, not a recommendation.

Studies of navitoclax in 256 cancer patients used oral doses from 10 to 475 mg. Those studies gave navitoclax on a 14 of 21 day schedule or as a continuous once daily schedule.

Source: PubMed abstract: Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia. ↗

Roughly what it costs

The one product we list that contains Senolytics costs $35, as read from the makers' pages. See the products

Questions to ask your doctor

  • Is Senolytics a sensible option for me, given my health and the medicines I take?
  • Could Senolytics interact with any medicine or supplement I already take?
  • What side effects should I watch for, and when should I stop or call you?
  • Would Senolytics be used for its approved purpose, or off-label for aging?
  • How would we tell whether it is helping, and when should we review it?

This is general information gathered from the sources listed, not medical advice. Talk to your doctor before starting anything new.

Products that contain it

Read from each maker's page. The research stage is for the ingredient, not proof that a product works.

What experts say

No expert views collected yet. Each one we add names the person and links to where they said it.

Commentary in journals

Cancer letters · Tony Tzeng YD, Hsiao JH, Li CJ · Aug 14, 2026

Targeting ferroptosis dependency as a new senolytic frontier. ↗

American journal of physiology. Heart and circulatory physiology · Fleenor BS, Adil MS · Dec 18, 2025

Senolytic intervention to mitigate the "red devil"-mediated vascular endothelial dysfunction. ↗

Recent research

See all research on Senolytics →

Trials

ClinicalTrials.gov lists 41 registered trials that mention Senolytics, for any condition (the count in The science below). Here we show the ones about aging. See them all ↗

Find Senolytics trials near you →

The science

Counted from PubMed and ClinicalTrials.gov on Oct 17, 2026, using one search for Senolytics in relation to aging. Each link opens the exact search.

Randomized trials in people
11 search ↗
Large trials (multicenter or phase 3)
1 search ↗
Phase 3 trials
0 search ↗
Trials in people
20 search ↗
Studies that watched people over time
19 search ↗
Animal and lab studies
371 search ↗
Registered trials
41 search ↗

PubMed search used

(senolytic*[tiab] OR "dasatinib and quercetin"[tiab] OR "dasatinib plus quercetin"[tiab])

Counts are search results, so they include some records that only mention Senolytics. How we count

Cite or share this page

Cite this page (APA)

Longevity Verdict. (n.d.). Senolytics: Research stage and evidence. Retrieved October 17, 2026, from https://longevityverdict.com/treatments/senolytics

Embed the research stage on your site

<iframe src="https://longevityverdict.com/embed/stage/senolytics" title="Senolytics: research stage on Longevity Verdict" width="340" height="72" style="border:0" loading="lazy"></iframe>

The badge shows this treatment's current research stage and links back here. It updates by itself when the stage changes.

Report a problem